Alireza Ziaei Torbati, PhD
Scientist
Harvard Medical School

Websites
favorite icon IntechOpen



Dr. Alireza Ziaei is a Fellow in the Ferenc Jolesz National Center for Image-Guided Therapy Multidisciplinary Program. He joined Surgical Planning Laboratory at Brigham & Women’s Hospital, Harvard Medical School in 2016 and his primary research is on evaluating qualitative and quantitative multiparametric MRI in assessment of aggressive tumors. Other aspects of his research include analyzing images with segmentation and volumetric tools for measurements on MRI images using 3D Slicer software to develop an automated application to MRI guided biopsy and processing diagnostic imaging for surgical planning. Dr. Ziaei received his M.D. with high honors from Iran followed by Postdoctoral Fellowship at Schepens Research Institute, Massachusetts Eye & Ear at Harvard Medical School and Chobanian and Avedisian School of Medicine, where he is trained and experienced in a wide spectrum of basic science to the bedside. Dr. Ziaei published and presented numerous articles in highly ranked peer reviewed journals and conferences, and his works has been recognized several times. He is a recipient of numerous awards including National Young Investigator Award, National Excellent Researchers and Best Article Symposium Awards.

Postdoctoral Fellow (Previously held)
Boston University Chobanian & Avedisian School of Medicine


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Taghipour M, Ziaei A, Alessandrino F, Hassanzadeh E, Harisinghani M, Vangel M, Tempany CM, Fennessy FM. Investigating the role of DCE-MRI, over T2 and DWI, in accurate PI-RADS v2 assessment of clinically significant peripheral zone prostate lesions as defined at radical prostatectomy. Abdom Radiol (NY). 2019 04; 44(4):1520-1527. PMID: 30361870; PMCID: PMC6440804; DOI: 10.1007/s00261-018-1807-6;
     
  2. Alessandrino F, Taghipour M, Hassanzadeh E, Ziaei A, Vangel M, Fedorov A, Tempany CM, Fennessy FM. Predictive role of PI-RADSv2 and ADC parameters in differentiating Gleason pattern 3?+?4 and 4?+?3 prostate cancer. Abdom Radiol (NY). 2019 01; 44(1):279-285. PMID: 30066169; PMCID: PMC6349548; DOI: 10.1007/s00261-018-1718-6;
     
  3. Mehrtash A, Ghafoorian M, Pernelle G, Ziaei A, Heslinga FG, Tuncali K, Fedorov A, Kikinis R, Tempany CM, Wells WM, Abolmaesumi P, Kapur T. Automatic Needle Segmentation and Localization in MRI With 3-D Convolutional Neural Networks: Application to MRI-Targeted Prostate Biopsy. IEEE Trans Med Imaging. 2019 04; 38(4):1026-1036. PMID: 30334789; PMCID: PMC6450731; DOI: 10.1109/TMI.2018.2876796;
     
  4. Sahin O, Ziaei A, Karaismailoglu E, Taheri N. The serum angiotensin converting enzyme and lysozyme levels in patients with ocular involvement of autoimmune and infectious diseases. BMC Ophthalmol. 2016 Feb 16; 16:19. PMID: 26879979; PMCID: PMC4754809; DOI: 10.1186/s12886-016-0194-4;
     
  5. Mosavar A, Ziaei A, Kadkhodaei M. The effect of implant thread design on stress distribution in anisotropic bone with different osseointegration conditions: a finite element analysis. Int J Oral Maxillofac Implants. 2015 Nov-Dec; 30(6):1317-26. PMID: 26478976; DOI: 10.11607/jomi.4091;
     
  6. Sahin O, Ziaei A. The role of methotrexate in resolving ocular inflammation after specific therapy for presumed latent syphilitic uveitis and presumed tuberculosis-related uveitis. Retina. 2014 Jul; 34(7):1451-9. PMID: 24531737; DOI: 10.1097/IAE.0000000000000080;
     
  7. Nassiri N, Sheibani K, Safi S, Nassiri S, Ziaei A, Ziaee A, Haji F, Mehravaran S, Nassiri N. Central Corneal Thickness in Highly Myopic Eyes: Inter-device Agreement of Ultrasonic Pachymetry, Pentacam and Orbscan II Before and After Photorefractive Keratectomy. J Ophthalmic Vis Res. 2014 Jan; 9(1):14-21. PMID: 24982727; PMCID: PMC4074469
     
  8. Ziaei A, Schmedt T, Chen Y, Jurkunas UV. Sulforaphane decreases endothelial cell apoptosis in fuchs endothelial corneal dystrophy: a novel treatment. Invest Ophthalmol Vis Sci. 2013 Oct 15; 54(10):6724-34. PMID: 24030461; PMCID: PMC3797593; DOI: 10.1167/iovs.13-12699;
     
  9. Nassiri N, Eslani M, Panahi N, Mehravaran S, Ziaei A, Djalilian AR. Ocular graft versus host disease following allogeneic stem cell transplantation: a review of current knowledge and recommendations. J Ophthalmic Vis Res. 2013 Oct; 8(4):351-8. PMID: 24653823; PMCID: PMC3957042
     
  10. Bitar MS, Liu C, Ziaei A, Chen Y, Schmedt T, Jurkunas UV. Decline in DJ-1 and decreased nuclear translocation of Nrf2 in Fuchs endothelial corneal dystrophy. Invest Ophthalmol Vis Sci. 2012 Aug 24; 53(9):5806-13. PMID: 22836768; PMCID: PMC3428112; DOI: 10.1167/iovs.12-10119;
     
Showing 10 of 12 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 12 publications over 8 distinct years, with a maximum of 2 publications in 2011 and 2013 and 2014 and 2019

YearPublications
20112
20121
20132
20142
20151
20161
20181
20192

Contact for Mentoring:

72 E. Concord St Instructional (L)
Boston MA 02118
Google Map

617.638.4583
Download vCard

Ziaei Torbati's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
See all (110) concept(s)
_
Similar People
See all (60) people
_